Nisa Investment Advisors’s Castle Biosciences CSTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.29K Sell
256
-25
-9% -$819 ﹤0.01% 2399
2025
Q4
$10.9K Sell
281
-83
-23% -$2.68K ﹤0.01% 2174
2025
Q3
$8.29K Buy
364
+44
+14% +$894 ﹤0.01% 2329
2025
Q2
$6.53K Sell
320
-16
-5% -$296 ﹤0.01% 2398
2025
Q1
$6.73K Sell
336
-109
-24% -$2.7K ﹤0.01% 2188
2024
Q4
$11.9K Hold
445
﹤0.01% 2091
2024
Q3
$12.7K Buy
445
+54
+14% +$1.37K ﹤0.01% 2047
2024
Q2
$8.51K Buy
391
+63
+19% +$1.4K ﹤0.01% 2191
2024
Q1
$7.26K Buy
328
+8
+3% +$174 ﹤0.01% 2084
2023
Q4
$6.91K Sell
320
-537
-63% -$9.45K ﹤0.01% 2091
2023
Q3
$14.5K Sell
857
-163
-16% -$2.85K ﹤0.01% 2102
2023
Q2
$14K Sell
1,020
-64
-6% -$1.3K ﹤0.01% 2190
2023
Q1
$25K Buy
1,084
+920
+561% +$22.5K ﹤0.01% 1933
2022
Q4
$4K Hold
164
﹤0.01% 2307
2022
Q3
$4K Buy
164
+24
+17% +$673 ﹤0.01% 2315
2022
Q2
$3K Hold
140
﹤0.01% 2313
2022
Q1
$6K Sell
140
-60
-30% -$2.48K ﹤0.01% 2282
2021
Q4
$9K Sell
200
-200
-50% -$10.5K ﹤0.01% 2039
2021
Q3
$27 Hold
400
﹤0.01% 2036
2021
Q2
$29 Hold
400
﹤0.01% 2055
2021
Q1
$27 Hold
400
﹤0.01% 2083
2020
Q4
$27K Buy
+400
New +$21.7K ﹤0.01% 2084

Other funds holding CSTL

Nisa Investment Advisors's CSTL Position: Q1 2026 in Review

Nisa Investment Advisors reduced its Castle Biosciences (CSTL) stake by 8.9% in Q1 2026, selling an estimated $819 and leaving 256 shares worth $6.29K. The position accounts for ﹤0.01% of the portfolio, ranked #2399.

Nisa Investment Advisors first reported a position in CSTL in Q4 2020 and has held it in 22 quarters since. The position peaked at $27K in Q4 2020. 186 funds tracked by Wall St. Rank hold CSTL as of Q1 2026.

  • Nisa Investment Advisors held 256 shares of Castle Biosciences worth $6.29K as of Q1 2026.
  • Nisa Investment Advisors sold 25 Castle Biosciences shares in Q1 2026, an estimated $819.
  • Castle Biosciences made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q1 2026, its #2399 holding.
  • Nisa Investment Advisors first reported a position in Castle Biosciences in Q4 2020 and has held it in 22 quarters since.
  • Nisa Investment Advisors's Castle Biosciences position peaked at $27K in Q4 2020.
  • 186 funds tracked by Wall St. Rank held Castle Biosciences as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.